Medical device regulatory consulting firm Emergo Group Inc. has acquired Mediqol Ltd. based in Sheffield, England. The acquisition greatly expands the Emergo Group presence in Europe, enhancing the consultancy's ability to serve medical device clients in the United Kingdom and rest of Europe.
(PRWEB) February 4, 2010 -- Emergo Group Inc., a global medical device consulting firm, has acquired Mediqol Ltd. based in Sheffield, England. Mediqol is UK’s largest privately owned medical device regulatory compliance consultancy. Both firms assist medical device manufacturers to obtain regulatory clearance to sell their products worldwide.
Over the past year, Emergo Group has expanded its European presence by opening an office in France in addition to its existing office in The Netherlands. With the Mediqol acquisition, Emergo Group now maintains three offices in Europe.
Emergo Group’s CEO, Rene van de Zande, notes: “The Mediqol consulting team is well respected in the UK with strong expertise in regulatory compliance for high risk medical devices. Their service approach providing assistance throughout the entire life-cycle of a medical device, from initial conception and product feasibility right through to clinical trials, regulatory approval and post-market surveillance, is very appealing to the clients we serve.”
The acquisition is part of Emergo Group’s long term strategy of becoming a “one stop” resource for international regulatory compliance for medical device and IVD companies around the world. The consultancy has currently offices in the US, Canada, Mexico, Brazil, France, Netherlands, United Kingdom, Japan, China and Australia, and a presence in India, South Korea and Russia.
Colin Rylett, Managing Director of Mediqol Ltd. notes: “Mediqol has a concentration of medical device clients in the UK who are eager to expand into international markets. We are pleased to have joined Emergo Group and look forward to providing a broader array of global consulting services to our combined client base.”
Mediqol Ltd has changed its name to Emergo UK Ltd and Mr. Rylett has taken on the position of Managing Director, Europe for the company.
Emergo Group assists medical device and IVD companies with international regulatory approvals, quality assurance, clinical trials and distribution consulting. The company has more than 1,200 medical device and IVD clients in 40 countries worldwide and maintains offices in North America, South America, Europe and Asia. Emergo Group was founded in 1997 and is headquartered in Austin, Texas.
Read the full story at http://www.prweb.com/releases/2010/02/prweb3561554.htm.
Copyright©2010 Vocus, Inc.
All rights reserved